Raymond James & Associates’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$5.61M Sell
128,666
-9,275
-7% -$309K ﹤0.01% 1584
2024
Q2
$3.86M Sell
137,941
-20,003
-13% -$528K ﹤0.01% 1776
2024
Q1
$4.25M Sell
157,944
-38,390
-20% -$1.09M ﹤0.01% 1702
2023
Q4
$5.51M Sell
196,334
-25,594
-12% -$605K ﹤0.01% 1473
2023
Q3
$4.71M Buy
221,928
+6,963
+3% +$190K ﹤0.01% 1492
2023
Q2
$7.31M Buy
214,965
+995
+0.5% +$33.1K 0.01% 1245
2023
Q1
$6.93M Buy
213,970
+38,060
+22% +$1.26M 0.01% 1250
2022
Q4
$5.9M Sell
175,910
-14,651
-8% -$447K 0.01% 1302
2022
Q3
$5.76M Buy
190,561
+23,721
+14% +$869K 0.01% 1276
2022
Q2
$5.81M Buy
166,840
+57,677
+53% +$2.27M 0.01% 1303
2022
Q1
$5.69M Buy
109,163
+105,058
+2,559% +$5.29M ﹤0.01% 1419
2021
Q4
$206K Buy
4,105
+416
+11% +$27.1K ﹤0.01% 3682
2021
Q3
$298K Buy
+3,689
New +$270K ﹤0.01% 3419

Other funds holding DOCS